$0.00 0.00 (0%)
11/25/2009 2:21 PM

BodyTel Scientific, Inc. (BDYT.OB)

CAPS Rating: 1 out of 5

The Company is currently in the development stage, and has no operations.

Results 1 - 7 of 7

Recs

1
Member Avatar supersizeme10 (< 20) Submitted: 4/7/2008 4:15:59 PM : Outperform Start Price: $3.25 BDYT.OB Score: -83.28

http://www.glengaryventures.com/rosenfeldprofile.php

I have followed this guy and his team for a number of years now - smart guy and very well connected.............if he is on board then its plain sailing ahead!

Recs

4
Member Avatar krissy85 (< 20) Submitted: 2/15/2008 6:18:01 PM : Outperform Start Price: $2.95 BDYT.OB Score: -83.40

first to the market with this kind of product - industry feed back i am hearing is very positive - CE approval is coming post positive ISO certification - sales and distribution agreements already in place.........huge market - growing market - high margin business with high turnover and re-curring earnings form strips - only pure play diabetic company on the market that allows investors to capture demand for meters, strips combined plus the added kicker of telemedicine through innovative bluetooth meter.......see their website for video on product and market - impressive!

Recs

0
Member Avatar withoutlimits (88.22) Submitted: 12/31/2007 3:31:59 AM : Underperform Start Price: $2.78 BDYT.OB Score: +77.49

Recent rise will make for a longer fall.

Recs

0
Member Avatar MJKpayday (97.88) Submitted: 12/29/2007 9:18:18 AM : Underperform Start Price: $2.78 BDYT.OB Score: +77.49

A 200M market cap all by one guy?

Recs

0
Member Avatar pranaclimber30 (68.54) Submitted: 11/14/2007 4:18:06 PM : Underperform Start Price: $2.76 BDYT.OB Score: +78.18

Awaiting CE and FDA approvals for their GlucoTel monitoring device for diabetics. Should do well after that. They expect the CE approval by December and the FDA approval by the second quarter of '08.

Recs

0
Member Avatar kfriel795 (32.25) Submitted: 10/4/2007 9:15:58 PM : Underperform Start Price: $2.52 BDYT.OB Score: +73.89

just not going to do well

Recs

0
Member Avatar zimn0016 (82.42) Submitted: 8/20/2007 11:01:36 PM : Outperform Start Price: $2.50 BDYT.OB Score: -79.60

Obesity causes diabetes (type II), Americans are becoming more obese = huge market. They don't have to deal with long phase trials with the FDA = little debt/investment. Seems like a quality spec play to me!

Results 1 - 7 of 7

Featured Broker Partners